Switch to:
Pfizer Inc  (NYSE:PFE) Cash Flow from Financing: \$-11,590 Mil (TTM As of Jun. 2017)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2017, Pfizer Inc paid \$0 Mil more to buy back shares than it received from issuing new shares. It spent {COMPANY->currency_symbol}{NetIssuanceofDebt_last_f} Mil paying down its debt. It paid \$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent \$1,910 Mil paying cash dividends to shareholders. It received \$90 Mil on other financial activities. In all, Pfizer Inc spent \$3,001 Mil on financial activities for the three months ended in Jun. 2017.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Pfizer Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Cash Flow from Financing -15,999.00 -14,975.00 -10,187.00 -10,409.00 -8,921.00

Pfizer Inc Quarterly Data

 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Cash Flow from Financing 1,918.00 -1,440.00 -2,228.00 -4,921.00 -3,001.00

Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Pfizer Inc's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

 Cash Flow from Financing (A: {A1}) = Net Issuance of Stock + Net Issuance of Debt + Net Issuance of Preferred Stock + Cash Flow for Dividends + Other Financing = -5000 + 2573 + 0 + -7317 + 823 = -8,921

Pfizer Inc's Cash from Financing for the quarter that ended in Jun. 2017 is

 Cash Flow from Financing (Q: Jun. 2017 ) = Net Issuance of Stock + Net Issuance of Debt + Net Issuance of Preferred Stock + Cash Flow for Dividends + Other Financing = 0 + -1181 + {NetIssuanceofpreferred_last}} + -1910 + 90 = -3,001

Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2017 was -1440 (Sep. 2016 ) + -2228 (Dec. 2016 ) + -4921 (Mar. 20 ) + -3001 (Jun. 2017 ) = \$-11,590 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Pfizer Inc's net issuance of stock for the three months ended in Jun. 2017 was \$0 Mil. Pfizer Inc paid \$0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Pfizer Inc's net issuance of debt for the three months ended in Jun. 2017 was \$-1,181 Mil. Pfizer Inc spent \$1,181 Mil paying down its debt.

3. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Pfizer Inc's net issuance of preferred for the three months ended in Jun. 2017 was \$0 Mil. Pfizer Inc paid \$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Pfizer Inc's cash flow for dividends for the three months ended in Jun. 2017 was \$-1,910 Mil. Pfizer Inc spent \$1,910 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Pfizer Inc's other financing for the three months ended in Jun. 2017 was \$90 Mil. Pfizer Inc received \$90 Mil on other financial activities.

Related Terms